MARKER THERAPEUTICS, INC. Accounts Payable
MARKER THERAPEUTICS, INC. (MRKR) had Accounts Payable of $585.04 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $585.04K.
- 2026-03-31: Accounts Payable, Current $1.50M.
- 2025-12-31: Accounts Payable, Current $793.73K.
- 2025-09-30: Accounts Payable, Current $951.00K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $585.04K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.50M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $793.73K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $951.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.72M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.30M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.07M 10-K · filed 2026-03-18 | $1.07M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.90M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.08M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.20M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $961.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.17M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.33M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.86M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.10M 10-K · filed 2024-03-26 | $1.61M 10-K · filed 2023-03-22 |
| 2022-09-30 | $2.02M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.77M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $5.02M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $5.14M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $2.33M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.04M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $1.89M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $2.94M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $3.70M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $2.81M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.66M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $993.00K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $1.37M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.44M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.67M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.62M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $1.01M 10-K · filed 2019-03-15 | |
| 2017-03-31 | $688.35K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $680.00K 10-K · filed 2018-03-23 | $680.18K 10-K · filed 2017-03-14 |
| 2015-12-31 | $691.09K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |